as on December 10, 2025 at 2:29 am IST
Day's Low
Day's High
-0.22%
Downside
4.77%
Upside
52 Week's Low
52 Week's High
44.03%
Downside
14.97%
Upside
Check Sophia Genetics Sa market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$329.1M
EPS (TTM)
-1.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-68.6M
Revenue (TTM)
73.3M
Profit Margin
-102.29%
Return On Equity TTM
-86.09%
Compare market cap, revenue, PE, and other key metrics of Sophia Genetics Sa with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $329.1M | NA | NA | -102.29% | |
| BUY | $39.8B | -7.66% | 47.17 | 27.93% | |
| HOLD | $8.6B | NA | 36.74 | 40.72% | |
| BUY | $39.0B | NA | 17.69 | 10.95% | |
| NA | $13.6B | NA | -25.89 | -18.45% |
The Sophia Genetics Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sophia Genetics Sa investment value today
Current value as on today
₹1,43,065
Returns
₹43,065
(+43.06%)
Returns from Sophia Genetics Sa Stock
₹37,202 (+37.2%)
Dollar Returns*
₹5,862 (+5.86%)
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Sophia Genetics Sa. Average target price of $7.33
Get share price movements and forecasts by analysts on Sophia Genetics Sa.
What analysts predicted
37.11%UPSIDE
Target Price
$7.33
Current Price
$4.61
Analyzed by
10 Analysts
Target
$7.33
Sophia Genetics Sa target price $7.33, a slight upside of 37.11% compared to current price of $4.61. According to 10 analysts rating.
Search interest for Sophia Genetics Sa Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 04 November
Wed, 00:19 AM
-SOPHiA GENETICS launches SOPHiA DDM Digital Twins, an AI-powered tool for cancer treatment simulations.
Wed, 06:34 AM
-SOPHiA GENETICS reports 23% revenue growth in Q3, raises 2025 revenue guidance to $75-$77 million.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -22.41M → -20.02M (in $), with an average increase of 12.0% per quarter
Revenue Rich
![]()
Revenue is up for the last 7 quarters, 15.77M → 19.46M (in $), with an average increase of 3.4% per quarter
Price Rise
![]()
In the last 3 months, SOPH stock has moved up by 49.4%
Best in 3 Years
![]()
In the last 3 years, SOPH has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Tempus Ai has given 65.7% return, outperforming this stock by 20.6%
| Organisation | Sophia Genetics Sa |
| Headquarters | La PiEce 12, Rolle, Switzerland, 1180 |
| Industry | Technology |
| CEO | Dr. Jurgi Camblong M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Manuela Da Silva Valente B.A. | Executive VP & Chief People Officer |
Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive VP, Chief Medical Officer & Chief Product Officer |
Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, CEO & Director |
Mr. George A. Cardoza M.B.A. | Executive VP & CFO |
Dr. Zhenyu Xu Ph.D. | Executive VP & Chief Scientific Officer |
Mr. Daan van Well L.L.M., M.B.A. | Executive VP, Chief Legal & Regulatory Officer |
Mr. Kevin Puylaert | VP & MD of EMEA |
Mr. Ross Jordan Muken B.Sc. | President |
Mr. Abhimanyu Verma | Senior VP & CTO |
Kellen Sanger | Head of Strategy and Investor Relations |
Sophia Genetics Sa share price today is $4.61 as on at the close of the market. Sophia Genetics Sa share today touched a day high of $4.83 and a low of $4.62.
Sophia Genetics Sa share touched a 52 week high of $5.3 on and a 52 week low of $2.58 on . Sophia Genetics Sa stock price today i.e. is closed at $4.61,which is 13.02% down from its 52 week high and 78.68% up from its 52 week low.
Sophia Genetics Sa market capitalisation is $0.00T as on .
Indian investors can start investing in Sophia Genetics Sa (SOPH) shares with as little as ₹89.831 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.31 in Sophia Genetics Sa stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sophia Genetics Sa share’s latest price of $4.61 as on December 10, 2025 at 2:29 am IST, you will get 2.1692 shares of Sophia Genetics Sa. Learn more about
fractional shares .